DuPont de Nemours, Inc.
Recent
price
P/E
ratio
div
yld
2.22%
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- DuPont de Nemours, Inc. (NYSE: DD) develops and manufactures high-performance engineered products and technology-based materials serving healthcare, water treatment, electronics, transportation, construction, safety and protection, and industrial applications worldwide. Headquartered in Wilmington, Delaware, and founded in 1802, the company operates through two primary segments: ElectronicsCo, which provides semiconductor fabrication consumables such as chemical mechanical planarization slurries, microlithography materials, electronic polymers, and specialty films for displays including organic light emitting diodes; and IndustrialsCo, which offers water purification solutions including reverse osmosis membranes and ion exchange resins, medical packaging and devices, high-performance fibers such as Kevlar and Nomex, automotive and aerospace materials for electric vehicles and engine efficiency, building products for energy efficiency and fire resilience, and flexographic printing and digital inks. The company maintains manufacturing facilities in the United States including Virginia, West Virginia, Alabama, and Texas, as well as internationally in Belgium and China, targeting semiconductor manufacturers, medical device producers, water treatment facilities, automotive and aerospace suppliers, construction firms, and industrial equipment providers. Recent developments include the August 2025 agreement to divest its Aramids business encompassing Kevlar and Nomex brands to Arclin for approximately $1.8 billion, with the transaction expected to close in early 2026 to sharpen portfolio focus and enhance growth margins while retaining an equity interest; plans to spin off its ElectronicsCo business by the end of 2025 as Qnity; the July 2024 acquisition of medical device contract manufacturer Donatelle Plastics for $313 million to bolster capabilities in injection molding, liquid silicone rubber processing, and device assembly within its healthcare offerings; and a strategic cooperation agreement with Zhen Ding Technology Group announced in October 2024 to advance high-end printed circuit board applications.
Company News
DuPont Expands Bioprocessing Portfolio With New Chromatography Media
4,600 DuPont de Nemours, Inc. $DD Shares Purchased by Integrated Advisors Network LLC
DuPont Launches AmberChrom™ SIL Silica Gel for Chromatography to Advance Manufacturing of GLP-1 and Other Peptide Therapeutics
A 30.9% Yield Looks Incredible. The Dividend Math Tells Another Story
DD Gains on Innovation, Productivity and Strategic Acquisitions
DuPont de Nemours, Inc. $DD Stock: Krilogy Financial LLC Increases Position
DuPont Announces Regular Quarterly Dividend on Common Stock
GAMMA Investing LLC Grows Stock Position in DuPont de Nemours, Inc. $DD
Moody National Bank Trust Division Makes New Investment in DuPont de Nemours, Inc. $DD
DuPont de Nemours (NYSE:DD) & Marubeni (OTCMKTS:MARUY) Critical Analysis
DuPont Schedules Third Quarter 2026 Earnings Conference Call
DuPont Announces Winners of Third Annual Tyvek® Sustainable Healthcare Packaging Awards
Mitsubishi (OTCMKTS:MSBHF) and DuPont de Nemours (NYSE:DD) Financial Survey
DuPont Expands Sugar Separation Expertise With New Digital Tool
DuPont Launches Sugar Separation Advisor to Accelerate Sugar and Sweetener Purification
DuPont: Secular Growth And Margin Expansion Should Drive Good Upside
Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reduction
Squarepoint Ops LLC Lowers Holdings in DuPont de Nemours, Inc. $DD
Integrated Wealth Concepts LLC Sells 13,713 Shares of DuPont de Nemours, Inc. $DD
Here's Why You Should Hold DuPont Stock in Your Portfolio for Now